Correlation Between Edwards Lifesciences and Abbott Laboratories

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edwards Lifesciences and Abbott Laboratories at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edwards Lifesciences and Abbott Laboratories into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edwards Lifesciences and Abbott Laboratories, you can compare the effects of market volatilities on Edwards Lifesciences and Abbott Laboratories and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edwards Lifesciences with a short position of Abbott Laboratories. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edwards Lifesciences and Abbott Laboratories.

Diversification Opportunities for Edwards Lifesciences and Abbott Laboratories

0.82
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Edwards and Abbott is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Edwards Lifesciences and Abbott Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abbott Laboratories and Edwards Lifesciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edwards Lifesciences are associated (or correlated) with Abbott Laboratories. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abbott Laboratories has no effect on the direction of Edwards Lifesciences i.e., Edwards Lifesciences and Abbott Laboratories go up and down completely randomly.

Pair Corralation between Edwards Lifesciences and Abbott Laboratories

Assuming the 90 days horizon Edwards Lifesciences is expected to generate 1.03 times less return on investment than Abbott Laboratories. But when comparing it to its historical volatility, Edwards Lifesciences is 1.08 times less risky than Abbott Laboratories. It trades about 0.25 of its potential returns per unit of risk. Abbott Laboratories is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest  10,364  in Abbott Laboratories on September 1, 2024 and sell it today you would earn a total of  894.00  from holding Abbott Laboratories or generate 8.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Edwards Lifesciences  vs.  Abbott Laboratories

 Performance 
       Timeline  
Edwards Lifesciences 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Edwards Lifesciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Edwards Lifesciences may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Abbott Laboratories 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Abbott Laboratories are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Abbott Laboratories may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Edwards Lifesciences and Abbott Laboratories Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edwards Lifesciences and Abbott Laboratories

The main advantage of trading using opposite Edwards Lifesciences and Abbott Laboratories positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edwards Lifesciences position performs unexpectedly, Abbott Laboratories can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will offset losses from the drop in Abbott Laboratories' long position.
The idea behind Edwards Lifesciences and Abbott Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Global Correlations
Find global opportunities by holding instruments from different markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance